ABLIM2 | Actin binding LIM protein family, member 2 | | | | | | Tissue enhanced |
AC007421.1 | | | | | | | Tissue enhanced |
AC037459.4 | Uncharacterized protein | | | | | | Tissue enhanced |
AC104534.3 | Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial | | | | | | Tissue enhanced |
AC117395.1 | LOC646903 protein; Uncharacterized protein | | | | | | Tissue enhanced |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGBL1 | ATP/GTP binding protein-like 1 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
AL354898.1 | | | | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
ANK1 | Ankyrin 1, erythrocytic | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANKRD9 | Ankyrin repeat domain 9 | | | | | | Tissue enhanced |
ANO5 | Anoctamin 5 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ASB2 | Ankyrin repeat and SOCS box containing 2 | | | | | | Tissue enhanced |
ASB5 | Ankyrin repeat and SOCS box containing 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
BEST3 | Bestrophin 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
C11orf89 | Chromosome 11 open reading frame 89 | | | | | | Tissue enhanced |
C15orf27 | Chromosome 15 open reading frame 27 | Predicted membrane proteins
| | | | | Tissue enhanced |
C1orf170 | Chromosome 1 open reading frame 170 | | | | | | Tissue enhanced |
C1QTNF9 | C1q and tumor necrosis factor related protein 9 | Predicted secreted proteins
| | | | | Tissue enhanced |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | | | | Tissue enhanced |
CCDC28B | Coiled-coil domain containing 28B | Disease related genes
| | | | | Tissue enhanced |
CDNF | Cerebral dopamine neurotrophic factor | Predicted secreted proteins
| | | | | Tissue enhanced |
CECR2 | Cat eye syndrome chromosome region, candidate 2 | | | | | | Tissue enhanced |
CHRNA1 | Cholinergic receptor, nicotinic, alpha 1 (muscle) | Disease related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CLIC5 | Chloride intracellular channel 5 | Transporters
| | | | | Tissue enhanced |
CLTCL1 | Clathrin, heavy chain-like 1 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CNKSR1 | Connector enhancer of kinase suppressor of Ras 1 | Cancer-related genes
| | | | | Tissue enhanced |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CTD-2207O23.12 | Uncharacterized protein | | | | | | Tissue enhanced |
CTD-2210P24.4 | Uncharacterized protein | | | | | | Tissue enhanced |
DOK5 | Docking protein 5 | | | | | | Tissue enhanced |
DOK7 | Docking protein 7 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DUSP26 | Dual specificity phosphatase 26 (putative) | Enzymes
| | | | | Tissue enhanced |
EEF1A2 | Eukaryotic translation elongation factor 1 alpha 2 | Plasma proteins
| | | | | Tissue enhanced |
EN1 | Engrailed homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
EXTL1 | Exostosin-like glycosyltransferase 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
EYA4 | Eyes absent homolog 4 (Drosophila) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
FAM184B | Family with sequence similarity 184, member B | | | | | | Tissue enhanced |
FAM47E-STBD1 | FAM47E-STBD1 readthrough | Plasma proteins
| | | | | Tissue enhanced |
FLNC | Filamin C, gamma | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enhanced |
FNDC5 | Fibronectin type III domain containing 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
FZD9 | Frizzled family receptor 9 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GATS | GATS, stromal antigen 3 opposite strand | | | | | | Tissue enhanced |
GATSL1 | GATS protein-like 1 | | | | | | Tissue enhanced |
GATSL2 | GATS protein-like 2 | | | | | | Tissue enhanced |
GPD1 | Glycerol-3-phosphate dehydrogenase 1 (soluble) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
GPR157 | G protein-coupled receptor 157 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |